Real-world analysis of the celgene global drug safety database: Early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash
Lilia Weiss, Dianna Gary, Arlene S. Swern, John Freeman, Mary M. Sugrue
Research output: Contribution to journal › Article › peer-review
6Scopus
citations
Fingerprint
Dive into the research topics of 'Real-world analysis of the celgene global drug safety database: Early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash'. Together they form a unique fingerprint.